
Quarterly Updates30 May 2026, 07:52 pm
Evoq Remedies Reports FY26 Results; Qualified Opinion
AI Summary
Evoq Remedies Ltd submitted integrated financial results for the half year and year ended March 31, 2026. The auditor's report expresses a qualified opinion with material uncertainty related to going concern. The audit highlights non-compliance with provisions governing related party loans, specifically Sections 177, 185, 188, and 189 of the Companies Act, 2013, read with Accounting Standard 18. Loans aggregating ₹670.26 lakhs were extended to related parties without prior audit committee approval, violating prescribed conditions and thresholds.
Key Highlights
- Evoq Remedies' FY26 results come with a qualified audit opinion.
- Auditor notes material uncertainty related to the company's going concern.
- Company violated Sections 177, 185, 188, and 189 of Companies Act regarding related party loans.
- ₹670.26 lakhs in loans extended to related parties without audit committee approval.
Price Impact
More from EVOQ